Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Reversed Brexit: £250 million for Bart De Strooper's dementia research

The UK has pledged a budget of £250 million to the creation of the UK Dementia Research Institute (DRI). The institute hopes to assemble top-notch…


ADHD, a disorder cured by play

In 2013, a new BioWin project, NeuroAtt, was launched to arrive at a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to…


ALS: A fierce diagnosis

Do you remember the Ice Bucket Challenge? Back in 2014, it was used to create awareness and collect donations for research to combat ALS (Amyotrop…

POPULAR TAGS

Protein clumps cause ALS and FTLD

Written by DS on in the category news with the tags , .


Led by professor Ludo Van Den Bosch (VIB-KU Leuven), scientists from Belgium, the UK and the US have identified new processes that form protein “clumps” that are characteristic of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). How these proteins, which can bind RNA in normal cells, stick together has remained elusive until recently, when scientists demonstrated that they demix from the watery substance inside cells, much like oil separates from water. Van Den Bosch’s team sheds light onto the molecular interactions behind the process in patients with defects in the C9orf72 gene. Their results are featured on the cover of the leading journal Molecular Cell.

You might also be interested in "ALS: A fierce diagnosis"

Clumps of RNA-binding proteins occur naturally in normal neurons under times of stress in the form of stress granules (SGs), which precipitate from the water inside cells. However, in normal cells, the process of stress granule formation is tightly controlled, reversible and does not lead to disease. Scientists previously believed that hydrophobic interactions – or the protein’s inability to mix with water – caused the formation of stress granules. However, Steven Boeynaems and colleagues under guidance of Van Den Bosch showed that in patients with defects in the C9orf72 gene, a different process can also cause this demixing, which precedes the formation of these toxic protein aggregates.

Mutation makes it easier for proteins to aggregate

Stress granules normally behave as liquid protein droplets within in a cell, while protein aggregates do not. The C9orf72 mutation causes neurons to produce small, abnormal and highly-charged toxic proteins, or peptides. Yet, precisely how these peptides are toxic was not well-understood. The research team was able to observe in vitro that these peptides cause RNA-binding proteins to spontaneously stick together and change the dynamics of stress granules in cells, making them more like solids than liquids.

Van Den Bosch: “These observations give us more insight into the molecular process that leads to the clumping of RNA-binding protein in familial ALS and FTLD. It is believed that this process is an important step that occurs before the irreversible ‘sticking-together’ of the proteins, which is a pathological hallmark of these diseases. When enough of these clumps form, the neuron is unable to function and dies.”

Protein clump ‘antifreeze’

A multidisciplinary approach was vital to the study, with the lab of Peter Tompa (VIB-VUB) and the Switch Laboratory (VIB-KU Leuven) collaborating closely with Van Den Bosch’s lab. These research groups’ expertise in protein aggregation and structural biology was essential to the work. VIB’s mass spectrometry core facility also played a pivotal role in identifying which proteins were responsive to the conditions created by the toxic peptides.

Steven Boeynaems: “Based on our collaborative work, future studies could center around developing a molecular ‘antifreeze’ that prevents these liquid proteins from solidifying, thereby stopping protein aggregation and the death of neurons.”

Reference
Boeynaems et al., Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics,  Molecular Cell, 2017.

(Source: VIB)

Read more about: , .

RELATED ARTICLES
Reversed Brexit: £250 million for Bart De Strooper's dementia research

The UK has pledged a budget of £250 million to the creation of the UK Dementia Research Institute (DRI). The institute hopes to assemble top-notch…


ADHD, a disorder cured by play

In 2013, a new BioWin project, NeuroAtt, was launched to arrive at a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to…


ALS: A fierce diagnosis

Do you remember the Ice Bucket Challenge? Back in 2014, it was used to create awareness and collect donations for research to combat ALS (Amyotrop…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Flanders.bio XpandInnovation Janssen KU Leuven GSK UGent Itera Life Science Biowin V-Bio Ventures Turnstone

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.